P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma

Zengpeng Chi, Qimin Wang, Xin Wang, Dagang Li, Lei Tong, Yu Shi, Fang Yang, Qingyuan Guo, Jiawei Zheng, Zheng-Gang ChenScientific 2024 · DOI

TL;DR

This study identifies Proline 4-hydroxylase 2 (P4HA2) as a key driver of oral squamous cell carcinoma (OSCC) progression. P4HA2 promotes tumor growth, invasion, and metastasis by regulating the PI3K/AKT signaling pathway, suggesting it could be a valuable biomarker for prognosis and a potential therapeutic target.

What Problem Does This Paper Address?

Oral squamous cell carcinoma (OSCC) is a prevalent and aggressive cancer with a high mortality rate, often due to its tendency to invade and metastasize. Current treatments have limited success in improving survival for advanced cases. Understanding the molecular mechanisms behind OSCC's aggressive behavior, particularly its proliferation, invasion, and metastasis, is crucial for developing better diagnostic and therapeutic strategies. While P4HA2 is known to be involved in collagen synthesis and has been implicated in other cancers, its specific role and underlying mechanisms in OSCC were not well-understood. This paper aims to fill that knowledge gap by investigating P4HA2's expression, function, and molecular pathways in OSCC.

Methods

The researchers employed a multi-pronged approach:

  • Bioinformatics Analysis: They utilized public databases like TCGA, TIMER, UALCAN, GEPIA, and Kaplan-Meier plotter to analyze P4HA2 expression in OSCC tissues compared to normal tissues, and to correlate its expression with clinical features and patient survival. Gene Ontology (GO) analysis was used to predict potential functional pathways.
  • In Vitro Studies:
    • Cell Models: They created OSCC cell lines with either reduced P4HA2 expression (knockdown using shRNA) or increased expression (overexpression using plasmids).
  • Functional Assays: Standard assays were used to assess cell proliferation (CCK-8), cell cycle progression (flow cytometry), apoptosis (flow cytometry), cell migration (scratch test), and cell invasion (Transwell invasion assay).
  • Molecular Mechanism Analysis: Western blotting was used to measure protein levels of key molecules involved in cell cycle regulation (Cyclin D1, Survivin), matrix metalloproteinases (MMP-2, MMP-9), and the PI3K/AKT signaling pathway (PI3K, p-PI3K, AKT, p-AKT), as well as collagen I and IV.
  • In Vivo Studies:
    • Xenograft Tumor Model: Mice were injected with OSCC cells with either silenced or overexpressed P4HA2 to evaluate tumor growth and metastasis.
  • Pulmonary Metastasis Model: Mice were injected with OSCC cells to assess lung metastasis.
  • Histopathology: Hematoxylin and eosin (H&E) staining was used to examine tumor and lung tissues.

Datasets

The study utilized publicly available datasets for initial analysis:

  • TCGA (The Cancer Genome Atlas): For OSCC and normal tissue expression data.
  • TIMER (Tumor Immune Estimation Resource): For OSCC and normal tissue expression data.
  • UALCAN: For OSCC and normal tissue expression data, and correlation with clinical features.
  • GEPIA: For OSCC and normal tissue expression data and survival analysis.
  • Kaplan-Meier plotter: For survival analysis of OSCC patients based on P4HA2 expression.

The study also involved the collection of 44 fresh frozen OSCC tissue samples from patients at Qingdao Municipal Hospital.

Key Insights and Ideas

  • P4HA2 as a "Master Regulator" of OSCC Aggression: The study strongly suggests P4HA2 isn't just a bystander but actively drives OSCC's malignant potential. Its overexpression is linked to worse outcomes, and its manipulation directly impacts key cancer behaviors.
  • Collagen-Dependent PI3K/AKT Signaling: A significant mechanistic insight is the proposed link between P4HA2, collagen synthesis, and the PI3K/AKT pathway. P4HA2's role in collagen hydroxylation appears to be the trigger for activating this crucial signaling cascade, which is known to promote cancer growth and survival. This highlights a potential feedback loop or dependency that could be exploited therapeutically.
  • MMPs as Downstream Effectors: The study points to MMP-2 and MMP-9 as key downstream mediators of P4HA2's pro-metastatic effects, linking P4HA2's influence on collagen and PI3K/AKT to the enzymes responsible for breaking down the extracellular matrix.
  • Cell Cycle and Apoptosis Control: P4HA2's influence extends to fundamental cellular processes, regulating the cell cycle (via Cyclin D1) and apoptosis (via Survivin), further underscoring its broad impact on tumor cell behavior.

Key Results

  • P4HA2 is Overexpressed in OSCC: Bioinformatics analysis and experimental validation (qRT-PCR, IHC) confirmed significantly higher P4HA2 expression in OSCC tissues compared to normal adjacent tissues.
  • P4HA2 Correlates with Poor Prognosis: High P4HA2 expression was associated with advanced clinical stage, higher pathological grade, lymph node metastasis, and significantly shorter overall survival in OSCC patients.
  • P4HA2 Promotes Proliferation, Invasion, and Metastasis:
    • In vitro: Knockdown of P4HA2 suppressed OSCC cell proliferation, migration, and invasion, while overexpression had the opposite effect.
  • In vivo: Mice with silenced P4HA2 showed reduced tumor growth and lung metastasis compared to control groups.
  • Mechanistic Findings:
    • P4HA2 silencing led to decreased phosphorylation of PI3K and AKT.
  • P4HA2 overexpression led to increased phosphorylation of PI3K and AKT.
  • P4HA2 knockdown reduced MMP-2 and MMP-9 expression, while overexpression increased it.
  • P4HA2 influenced the expression of cell cycle regulator Cyclin D1 and apoptosis inhibitor Survivin.

Limitations and Future Work

  • Specific Molecular Interactions: While the study establishes a link between P4HA2, collagen, PI3K/AKT, and MMPs, the precise molecular interactions and signaling cascades require further elucidation. The authors explicitly state the need to "further clarify how P4HA2 affects MMP-2 and MMP-9 and to explore the specific molecular mechanisms by which P4HA2 regulates these enzymes."
  • Collagen-Dependent Mechanism: The study suggests a collagen-dependent regulation of PI3K/AKT signaling. Future work could delve deeper into how P4HA2's hydroxylation activity specifically impacts collagen structure and its downstream signaling effects.
  • Therapeutic Potential: While P4HA2 is proposed as a biomarker and therapeutic target, further research is needed to develop and test specific P4HA2 inhibitors or strategies to modulate its activity for OSCC treatment.
  • Broader Clinical Validation: While the study used 44 patient samples, larger cohort studies would be beneficial to further validate P4HA2 as a prognostic biomarker across diverse OSCC patient populations.

Summary updated

Abstract

Proline 4-hydroxylase 2 (P4HA2) is known for its hydroxylase activity, primarily involved in hydroxylating collagen precursors and promoting collagen cross-linking under physiological conditions. Although its overexpression influences a wide variety of malignant tumors' occurrence and development, its specific effects and mechanisms in oral squamous cell carcinoma (OSCC) remain unclear. This study focused on investigating the expression patterns, carcinogenic functions, and underlying mechanisms of P4HA2 in OSCC cells. Various databases, including TCGA, TIMER, UALCAN, GEPIA, and K-M plotter, along with paraffin-embedded samples, were used to ascertain P4HA2 expression in cancer and its correlation with clinicopathological features. P4HA2 knockdown and overexpression cell models were developed to assess its oncogenic roles and mechanisms. The results indicated that P4HA2 was overexpressed in OSCC and inversely correlated with patient survival. Knockdown of P4HA2 suppressed invasion, migration, and proliferation of OSCC cells both in vitro and in vivo, whereas overexpression of P4HA2 had the opposite effects. Mechanistically, the phosphorylation levels of the PI3K/AKT pathway were reduced following P4HA2 silencing. The study reveals that P4HA2 acts as a promising biomarker for predicting prognosis in OSCC and significantly affects metastasis, invasion, and proliferation of OSCC cells through the regulation of the PI3K/AKT signaling pathway.
BibTeX
@inproceedings{chi2024p,
  author = {Zengpeng Chi and Qimin Wang and Xin Wang and Dagang Li and Lei Tong and Yu Shi and Fang Yang and Qingyuan Guo and Jiawei Zheng and Zheng-Gang Chen},
  title = {{P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma}},
  booktitle = {Scientific},
  year = {2024},
  doi = {10.1038/s41598-024-64264-5},
}
Figure